Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) COO Sells $59,680.65 in Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) COO Amit Gupta sold 7,507 shares of the business’s stock in a transaction that occurred on Tuesday, July 2nd. The shares were sold at an average price of $7.95, for a total value of $59,680.65. Following the transaction, the chief operating officer now owns 129,518 shares of the company’s stock, valued at $1,029,668.10. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Amit Gupta also recently made the following trade(s):

  • On Wednesday, April 24th, Amit Gupta sold 23,416 shares of Cardlytics stock. The shares were sold at an average price of $11.91, for a total transaction of $278,884.56.

Cardlytics Price Performance

CDLX stock opened at $8.31 on Friday. Cardlytics, Inc. has a 52 week low of $5.69 and a 52 week high of $20.52. The firm has a market capitalization of $405.39 million, a P/E ratio of -1.88 and a beta of 1.65. The company has a fifty day simple moving average of $9.67 and a two-hundred day simple moving average of $9.54. The company has a quick ratio of 2.13, a current ratio of 2.13 and a debt-to-equity ratio of 1.30.

Cardlytics (NASDAQ:CDLXGet Free Report) last announced its earnings results on Wednesday, May 8th. The company reported ($0.35) earnings per share (EPS) for the quarter. Cardlytics had a negative net margin of 55.23% and a negative return on equity of 25.36%. The business had revenue of $67.61 million for the quarter. Analysts anticipate that Cardlytics, Inc. will post -1.8 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Cardlytics

Institutional investors have recently modified their holdings of the stock. Tower Research Capital LLC TRC raised its holdings in Cardlytics by 349.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 9,602 shares of the company’s stock valued at $88,000 after buying an additional 7,465 shares during the period. Banco Santander S.A. purchased a new position in shares of Cardlytics during the first quarter valued at approximately $199,000. SG Americas Securities LLC lifted its stake in shares of Cardlytics by 34.3% during the 4th quarter. SG Americas Securities LLC now owns 21,461 shares of the company’s stock worth $198,000 after acquiring an additional 5,484 shares during the last quarter. Clear Street Markets LLC purchased a new position in Cardlytics during the 4th quarter valued at $199,000. Finally, Check Capital Management Inc. CA grew its position in Cardlytics by 14.0% in the 4th quarter. Check Capital Management Inc. CA now owns 23,200 shares of the company’s stock valued at $214,000 after acquiring an additional 2,850 shares during the last quarter. 68.10% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on CDLX. Lake Street Capital increased their price objective on shares of Cardlytics from $13.00 to $18.00 and gave the stock a “buy” rating in a research note on Friday, March 15th. Northland Securities initiated coverage on Cardlytics in a research note on Tuesday, June 18th. They issued an “outperform” rating and a $14.00 price target for the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $12.00 price objective on shares of Cardlytics in a research note on Tuesday, June 11th. Bank of America reaffirmed a “neutral” rating and set a $11.00 price objective on shares of Cardlytics in a report on Thursday, June 20th. Finally, Northland Capmk upgraded shares of Cardlytics to a “strong-buy” rating in a research note on Tuesday, June 18th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $12.67.

Check Out Our Latest Stock Report on Cardlytics

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Recommended Stories

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.